ask="N/A"
ask_size="N/A"
average_daily_volume="186180"
bid="12.15"
bid_size="100"
book_value="6.18"
change="+1.10"
change_from_200_day_moving_average="1.47"
change_from_50_day_moving_average="-0.76"
change_from_52_week_high="-4.90"
change_From_52_week_low="7.05"
change_in_percent="+6.01%"
close="19.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.18"
ebitda="-77.71M"
eps_estimate_current_year="-3.62"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-3.96"
ex_dividend_date="N/A"
float_shares="19254000"
high="19.60"
high_52_weeks="24.30"
last_trade_date="3/15/2017"
last_trade_price="19.40"
last_trade_size="7925"
last_trade_time="4:00pm"
low="18.30"
low_52_weeks="12.35"
market_capitalization="568.79M"
moving_average_200_day="17.93"
moving_average_50_day="20.16"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="18.40"
pe_ratio="N/A"
peg_ratio="-0.45"
percent_change_from_200_day_moving_average="+8.18%"
percent_change_from_50_day_moving_average="-3.77%"
percent_change_from_52_week_high="-20.16%"
percent_change_from_52_week_low="+57.09%"
previous_close="18.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.96"
price_per_sales="1788.46"
revenue="300000.00"
shares_outstanding="29319000"
short_ratio="27.60"
stock_exchange="NGM"
symbol="RVNC"
volume="184352"
weeks_range_52="12.35 - 24.30"
